CBT
TEVA icon

Crews Bank & Trust’s Teva Pharmaceuticals TEVA Stock Holding History

Crews Bank & Trust’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.2K Hold
300
– – ﹤0.01% 539
2026
Q1 		$9.04K Hold
300
– – ﹤0.01% 539
2025
Q4 		$9.36K Hold
300
– – ﹤0.01% 530
2025
Q3 		$6.06K Hold
300
– – ﹤0.01% 553
2025
Q2 		$5.03K Buy
+300
New +$4.84K ﹤0.01% 561

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Crews Bank & Trust's TEVA Position: Q2 2026 in Review

Crews Bank & Trust held its Teva Pharmaceuticals (TEVA) position steady in Q2 2026 at 300 shares worth $10.2K. The position accounts for ﹤0.01% of the portfolio, ranked #539.

Crews Bank & Trust first reported a position in TEVA in Q2 2025 and has held it in 5 quarters since. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Crews Bank & Trust held 300 shares of Teva Pharmaceuticals worth $10.2K as of Q2 2026.
  • Crews Bank & Trust left its Teva Pharmaceuticals share count unchanged in Q2 2026.
  • Teva Pharmaceuticals made up ﹤0.01% of Crews Bank & Trust's portfolio in Q2 2026, its #539 holding.
  • Crews Bank & Trust first reported a position in Teva Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Crews Bank & Trust's 13F filing for Q2 2026, filed 16 Jul 2026.